Christina Larkin
2019
In 2019, Christina Larkin earned a total compensation of $943.3K as Chief Operating Officer at Spero Therapeutics, a 77% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $158,000 |
---|---|
Option Awards | $271,837 |
Salary | $394,167 |
Stock Awards | $118,493 |
Other | $792 |
Total | $943,289 |
Larkin received $394.2K in salary, accounting for 42% of the total pay in 2019.
Larkin also received $158K in non-equity incentive plan, $271.8K in option awards, $118.5K in stock awards and $792 in other compensation.
Rankings
In 2019, Christina Larkin's compensation ranked 9,537th out of 13,971 executives tracked by ExecPay. In other words, Larkin earned more than 31.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,537 | 32nd |
Manufacturing | 3,836 | 33rd |
Chemicals And Allied Products | 1,456 | 34th |
Drugs | 1,244 | 34th |
Pharmaceutical Preparations | 924 | 34th |
Larkin's colleagues
We found two more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2019.